Glutamate release in human cerebral cortex and its modulation by 5-hydroxtryptamine acting at h 5-HT(1D) receptors

British Journal of Pharmacology

Volumn 123, Issue 1, 1998, Pages 45-50

  Maura, Guido ^b   Marcoli, Manuela ^b   Tortarolo, Massimo ^b   Andrioli, Gian Carlo ^a   Raiteri, Maurizio ^b  

^a GALLIERA HOSPITAL   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

5 hydroxytryptamine glutamate interaction; Glutamate release; h 5 HT(1D) receptor; Human cerebral cortex; Human native 5 hydroxytryptamine receptors

Indexed keywords

CALCIUM ION; GLUTAMIC ACID; KETANSERIN; METERGOLINE; METITEPINE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; POTASSIUM ION; SEROTONIN; SEROTONIN 1D RECEPTOR; SUMATRIPTAN;

ADULT; AGED; ARTICLE; BRAIN CORTEX; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MALE; MODULATION; NERVE ENDING; NEUROSURGERY; PRIORITY JOURNAL; SYNAPTOSOME;

ADULT; AGED; AMINO ACIDS; CALCIUM; CEREBRAL CORTEX; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GLUTAMIC ACID; HUMANS; MALE; MIDDLE AGED; RECEPTORS, GLUTAMATE; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SYNAPTOSOMES;

EID: 0031984344     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701581     Document Type: Article

References (45)

1. ASTON-JONES, G., AKAOKA, H., CHARLETY, P. & CHOUVET, G. (1991). Serotonin selectively attenuates glutamate-evoked activation of noradrenergic locus coeruleus neurons. J. Neurosci., 11, 760-769.
2. 1B receptors suppress low but not high frequency synaptic transmission in the rat subicular cortex in vitro. Brain Res., 721, 59-65.
3. BRADFORD, M.M. (1976). A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
4. 1D binding sites in various species: similar pharmacological profile in dog, monkey, calf, guinea-pig and human brain membranes. Naunyn-Schmiedeberg's Arch. Pharmacol., 346, 243-248.
5. CLOUGH, R., STATNICK, M., MARING-SMITH, M., WANG, C., EELLS, J., BROWNING, R., DAILEY, J. & JOBE, P. (1996). Fetal raphe transplants reduce seizure severity in serotonin-depleted GEPRs. NeuroReport, 8, 341-346.
6. FAVALE, E., RUBINO, V., MAINARDI, P., LUNARDI, G. & ALBANO, C. (1995). Anticonvulsant effect of fluoxetine in humans. Neurology, 45, 1926-1927.
7. 1Dβ receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 352, 451-454.
8. 1A receptors. Eur. J. Pharmacol., 237, 283-291.
9. 3H]hydroxytryptamine in slices of the human neocortex. J. Neurochem., 59, 1293-1301.
10. GLASS, J.D., SELIM, M., SRKALOVIC, G. & REA, M.A. (1995). Tryptophan loading modulates light-induced responses in the mammalian circadian system. J. Biol. Rhythms, 10, 80-90.
11. 1D serotonin receptors in rat: structural and pharmacological comparison of the two cloned receptors. Mol. Cell. Neurosci., 3, 578-587.
12. 1D-type serotonin receptor. Mol. Pharmacol., 40, 143-148.
13. 1D receptor subtypes. Trends Pharmacol. Sci., 17, 103-105.
14. 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes. J. Neurosci., 7, 894-903.
15. HOYER, D. & BODDEKE, H.W.G.M. (1993). Partial agonists, full agonists, antagonists: dilemmas of definition. Trends Pharmacol. Sci., 14, 270-275.
16. HOYER, D., CLARKE, D.E., FOZARD, J.R., HARTIG, P.R., MARTIN, G.R., MYLECHARANE, E.J., SAXENA, P.R. & HUMPHREY, P.A. (1994). International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev., 2, 157-203.
17. HOYER, D. & MIDDLEMISS, D.N. (1989). Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain. Trends Pharmacol. Sci., 10, 130-132.
18. 1B. Brain Res., 376, 85-96.
19. 2 receptors in serotonin induced contraction of human isolated coronary arteries. Circulation, 90, 1141-1153.
20. LOU, J.-S., GOLDFARB, I., MCSHANE, L., GATEV, P. & HALLETT, M. (1995). Use of buspirone for treatment of cerebellar ataxia. Arch. Neurol., 52, 982-988.
21. MANUEL, N.A., WALLIS, D.I. & CRICK, H. (1995). Ketanserin-sensitive depressant actions of 5-HT receptor agonists in the neonatal rat spinal cord. Br. J. Pharmacol., 116, 2647-2654.
22. MARTIN, G.R. & HUMPHREY, P.P.A. (1994). Classification Review. Receptors for 5-hydroxytryptamine: current perspectives on classification and nomenclature. Neuropharmacology, 33, 261-273.
23. MAURA, G., GUADAGNIN, A. & RAITERI, M. (1995). Low nanomolar serotonin inhibits the glutamate receptor nitric oxide/cyclic GMP pathway in slices from adult rat cerebellum. Neuroscience, 68, 455-463.
24. 1A receptors respectively mediate inhibition of glutamate release and inhibition of cyclic GMP production in rat cerebellum in vitro. J. Neurochem., 66, 203-209.
25. 1D autoreceptors in human cerebral cortex. J. Neurochem., 60, 1179-1182.
26. 1Dα receptor sites. Neuropharmacology, 34, 235-237.
27. 1D receptor sites. Pharmacol. Commun., 7, 309-316.
28. 1B receptors. Eur. J. Pharmacol. Mol. Pharmacol. Section, 290, 95-103.
29. 1B receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 353, 144-156.
30. 1D receptors. Br. J. Pharmacol., 119, 301P.
31. RAITERI, M., ANGELINI, F. & LEVI, G. (1974). A simple apparatus for studying the release of neurotransmitters from synaptosomes. Eur. J. Pharmacol., 25, 411-414.
32. 1 receptors modulating transmitter release in rat cerebellum. J. Pharmacol. Exp. Ther., 237, 644-648.
33. SCHLICKER, E., BRANDT, F., CLASSEN, K. & GÖTHERT, M. (1985). Serotonin release in human cerebral cortex and its modulation via serotonin receptors. Brain Res., 331, 337-341.
34. SIZER, A.R., KILPATRICK, G.J. & ROBERTS, M.K. (1992). A post-synaptic depressant modulatory action of 5-hydroxytryptamine on excitatory amino acid responses in rat entorhinal cortex in vitro. Neuropharmacology, 31, 531-539.
35. 1D receptor antagonist. Behav. Brain Res., 73, 157-161.
36. 1D receptor antagonist. Br. J. Pharmacol., 110, 9P.
37. SRKALOVIC, G., SELIM, M., REA, M.A. & GLASS, J.D. (1994). Serotonergic inhibition of extracellular glutamate in the suprachiasmatic nuclear region assessed using in vivo brain microdialysis. Brain Res., 656, 302-308.
38. TANAKA, E. & NORTH, R.A. (1993). Actions of 5-hydroxytryptamine on neurons of the rat cingulate cortex. J. Neurophysiol., 69, 1749-1757.
39. TONNAER, J.A.D.M., ENGELS, G.M.H., WIEGANT, V.M., BURBACH, J.P.H., DE JONG, W. & DE WIED, D. (1983). Proteolytic conversion of angiotensins in rat brain tissue. Eur. J. Biochem., 131, 415-421.
40. TROUILLAS, P., XIE, J. & ADELEINE, P. (1996). Treatment of cerebellar ataxia with buspirone: a double-blind study. Lancet, 348, 759.
41. 1A sur l'ataxie cérébelleuse: une étude pilote. Rev. Neurol. (Paris), 151, 708-713.
42. 1Dβ receptors. Eur. J. Pharmacol., 314, 365-372.
43. 1Dβ. Proc. Natl. Acad. Sci. U.S.A., 89, 3630-3634.
44. 1D subtypes. Naunyn-Schmiedeberg's Arch. Pharmacol., 354, 226-236.
45. 1Dβ receptor subtypes. Eur. J. Pharmacol. Mol. Pharmacol. Section, 291, 9-15.